testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT
- RxCUI
- 1599949
- RxNorm name
- testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT
- Display name
- testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT
- Full name
- testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:22
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Testosterone | TESTOSTERONE | Encube Ethicals, Inc. | ca5d4865-356b-45e7-b603-fe299e450abc | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | 1599949 |
| Testosterone | TESTOSTERONE | Lupin Pharmaceuticals, Inc. | 29c8846f-121c-4958-9e03-3bd271c21558 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | 1599949 |
| TESTOSTERONE | TESTOSTERONE | Alembic Pharmaceuticals Inc. | e39289aa-681c-47ec-9461-52e7f17e5d71 | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | 1599949 |
| testosterone | TESTOSTERONE | Padagis Israel Pharmaceuticals Ltd | c0c56607-e995-4bed-9c62-e33a722b38b5 | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | 1599949 |
| Testosterone | TESTOSTERONE | Cipla USA Inc. | 6a46b5de-5d95-4570-91a6-3e4278028c59 | 2025-06-04 | Boxed warning, Warnings, Adverse reactions | 1599949 |
| Testosterone | TESTOSTERONE | Actavis Pharma, Inc. | 7227ab2f-c8ef-4bab-92ab-3092182abcc9 | 2025-03-01 | Boxed warning, Warnings, Adverse reactions | 1599949 |
| testosterone | TESTOSTERONE | Bryant Ranch Prepack | 5be74193-de73-436d-a9a1-35a857bc8e0c | 2024-10-22 | Boxed warning, Warnings, Adverse reactions | 1599949 |
| testosterone | TESTOSTERONE | Bryant Ranch Prepack | d22a072f-529b-4878-90fc-4365d9dc67e6 | 2024-08-20 | Boxed warning, Warnings, Adverse reactions | 1599949 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d22a072f-529b-4878-90fc-4365d9dc67e6 | testosterone (as testosterone propionate) 2 % Topical Solution | SY | 106 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20240820 |
| d22a072f-529b-4878-90fc-4365d9dc67e6 | 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution | SCD | 106 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20240820 |
| d22a072f-529b-4878-90fc-4365d9dc67e6 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | SY | 106 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20240820 |
| d22a072f-529b-4878-90fc-4365d9dc67e6 | 60 ACTUAT testosterone 30 MG/1.5 ML ACTUAT Topical Solution | SY | 106 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20240820 |
| d22a072f-529b-4878-90fc-4365d9dc67e6 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | PSN | 106 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20240820 |
| 5be74193-de73-436d-a9a1-35a857bc8e0c | 60 ACTUAT testosterone 30 MG/1.5 ML ACTUAT Topical Solution | SY | 105 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20241022 |
| 5be74193-de73-436d-a9a1-35a857bc8e0c | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | PSN | 105 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20241022 |
| 5be74193-de73-436d-a9a1-35a857bc8e0c | 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution | SCD | 105 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20241022 |
| 5be74193-de73-436d-a9a1-35a857bc8e0c | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | SY | 105 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20241022 |
| 5be74193-de73-436d-a9a1-35a857bc8e0c | testosterone (as testosterone propionate) 2 % Topical Solution | SY | 105 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20241022 |
| 7227ab2f-c8ef-4bab-92ab-3092182abcc9 | testosterone (as testosterone propionate) 2 % Topical Solution | SY | 20 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20250301 |
| 7227ab2f-c8ef-4bab-92ab-3092182abcc9 | 60 ACTUAT testosterone 30 MG/1.5 ML ACTUAT Topical Solution | SY | 20 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20250301 |
| 7227ab2f-c8ef-4bab-92ab-3092182abcc9 | 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution | SCD | 20 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20250301 |
| 7227ab2f-c8ef-4bab-92ab-3092182abcc9 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | PSN | 20 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20250301 |
| 7227ab2f-c8ef-4bab-92ab-3092182abcc9 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | SY | 20 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20250301 |
| 29c8846f-121c-4958-9e03-3bd271c21558 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | SY | 13 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION USP safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION USP. TESTOSTERONE topical solution USP, for topical use, CIII Initial U.S. Approval: 1953 | 20260113 |
| 29c8846f-121c-4958-9e03-3bd271c21558 | 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution | SCD | 13 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION USP safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION USP. TESTOSTERONE topical solution USP, for topical use, CIII Initial U.S. Approval: 1953 | 20260113 |
| 29c8846f-121c-4958-9e03-3bd271c21558 | testosterone (as testosterone propionate) 2 % Topical Solution | SY | 13 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION USP safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION USP. TESTOSTERONE topical solution USP, for topical use, CIII Initial U.S. Approval: 1953 | 20260113 |
| 29c8846f-121c-4958-9e03-3bd271c21558 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | PSN | 13 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION USP safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION USP. TESTOSTERONE topical solution USP, for topical use, CIII Initial U.S. Approval: 1953 | 20260113 |
| 29c8846f-121c-4958-9e03-3bd271c21558 | 60 ACTUAT testosterone 30 MG/1.5 ML ACTUAT Topical Solution | SY | 13 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION USP safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION USP. TESTOSTERONE topical solution USP, for topical use, CIII Initial U.S. Approval: 1953 | 20260113 |
| c0c56607-e995-4bed-9c62-e33a722b38b5 | testosterone (as testosterone propionate) 2 % Topical Solution | SY | 10 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20250630 |
| c0c56607-e995-4bed-9c62-e33a722b38b5 | 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution | SCD | 10 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20250630 |
| c0c56607-e995-4bed-9c62-e33a722b38b5 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | PSN | 10 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20250630 |
| c0c56607-e995-4bed-9c62-e33a722b38b5 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | SY | 10 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20250630 |
| c0c56607-e995-4bed-9c62-e33a722b38b5 | 60 ACTUAT testosterone 30 MG/1.5 ML ACTUAT Topical Solution | SY | 10 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION . TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20250630 |
| e39289aa-681c-47ec-9461-52e7f17e5d71 | 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution | SCD | 9 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION. TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval:1953 | 20250714 |
| e39289aa-681c-47ec-9461-52e7f17e5d71 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | SY | 9 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION. TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval:1953 | 20250714 |
| e39289aa-681c-47ec-9461-52e7f17e5d71 | testosterone (as testosterone propionate) 2 % Topical Solution | SY | 9 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION. TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval:1953 | 20250714 |
| e39289aa-681c-47ec-9461-52e7f17e5d71 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | PSN | 9 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION. TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval:1953 | 20250714 |
| e39289aa-681c-47ec-9461-52e7f17e5d71 | 60 ACTUAT testosterone 30 MG/1.5 ML ACTUAT Topical Solution | SY | 9 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION. TESTOSTERONE topical solution, for topical use CIII Initial U.S. Approval:1953 | 20250714 |
| 6a46b5de-5d95-4570-91a6-3e4278028c59 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | PSN | 7 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION TESTOSTERONE topical solution, for topical use, CIII Initial U.S. Approval: 1953 | 20250604 |
| 6a46b5de-5d95-4570-91a6-3e4278028c59 | 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution | SCD | 7 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION TESTOSTERONE topical solution, for topical use, CIII Initial U.S. Approval: 1953 | 20250604 |
| 6a46b5de-5d95-4570-91a6-3e4278028c59 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | SY | 7 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION TESTOSTERONE topical solution, for topical use, CIII Initial U.S. Approval: 1953 | 20250604 |
| 6a46b5de-5d95-4570-91a6-3e4278028c59 | 60 ACTUAT testosterone 30 MG/1.5 ML ACTUAT Topical Solution | SY | 7 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION TESTOSTERONE topical solution, for topical use, CIII Initial U.S. Approval: 1953 | 20250604 |
| 6a46b5de-5d95-4570-91a6-3e4278028c59 | testosterone (as testosterone propionate) 2 % Topical Solution | SY | 7 | These highlights do not include all the information needed to use TESTOSTERONE TOPICAL SOLUTION safely and effectively. See full prescribing information for TESTOSTERONE TOPICAL SOLUTION TESTOSTERONE topical solution, for topical use, CIII Initial U.S. Approval: 1953 | 20250604 |
| 3b40e56a-51bb-4357-8861-325bb1195049 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | SY | 1 | These highlights do not include all the information needed to use AXIRON safely and effectively. See full prescribing information for AXIRON. AXIRON (testosterone) topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20131112 |
| 3b40e56a-51bb-4357-8861-325bb1195049 | 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution | SCD | 1 | These highlights do not include all the information needed to use AXIRON safely and effectively. See full prescribing information for AXIRON. AXIRON (testosterone) topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20131112 |
| 3b40e56a-51bb-4357-8861-325bb1195049 | 60 ACTUAT testosterone 30 MG/1.5 ML ACTUAT Topical Solution | SY | 1 | These highlights do not include all the information needed to use AXIRON safely and effectively. See full prescribing information for AXIRON. AXIRON (testosterone) topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20131112 |
| 3b40e56a-51bb-4357-8861-325bb1195049 | testosterone 2 % (30 MG/ACTUAT) Topical Solution, 60 ACTUAT | PSN | 1 | These highlights do not include all the information needed to use AXIRON safely and effectively. See full prescribing information for AXIRON. AXIRON (testosterone) topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20131112 |
| 3b40e56a-51bb-4357-8861-325bb1195049 | testosterone (as testosterone propionate) 2 % Topical Solution | SY | 1 | These highlights do not include all the information needed to use AXIRON safely and effectively. See full prescribing information for AXIRON. AXIRON (testosterone) topical solution, for topical use CIII Initial U.S. Approval: 1953 | 20131112 |